Sign in
4

Changes in Ownership

Caribou Biosciences, Inc. Filed Acc 0001209191-22-019808

VP of Finance and Controller acquired 2,274 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Fischesser Ryan · VP of Finance and Controller

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-15 Exercise or conversion : show line 1 in the form +1,136 $2.69 $3,056 112,106 D
2022-03-15 Exercise or conversion : show line 2 in the form +1,138 $4.11 $4,677 113,244 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-03-15 Exercise or conversion : show line 3 in the form Option to purchase Common Stock −1,136 5,679 D
2022-03-15 Exercise or conversion : show line 4 in the form Option to purchase Common Stock −1,138 19,314 D
Loading xslF345X03/doc4.xml…